Doris M. Benbrook

Affiliations: 
Biochemistry and Molecular Biology University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States 
Area:
Biochemistry, Cell Biology, Oncology, Medicine and Surgery
Google:
"Doris Benbrook"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nammalwar B, Bunce RA, Berlin KD, et al. (2019) Synthesis and biological evaluation of SHetA2 (NSC-721689) analogs against the ovarian cancer cell line A2780. European Journal of Medicinal Chemistry. 170: 16-27
Watts FM, Pouland T, Bunce RA, et al. (2018) Activity of oxygen-versus sulfur-containing analogs of the Flex-Het anticancer agent SHetA2. European Journal of Medicinal Chemistry. 158: 720-732
Benbrook DM, Janakiram NB, Chandra V, et al. (2017) Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. Investigational New Drugs
Janakiram NB, Mohammed A, Bryant T, et al. (2017) Loss of natural killer T (NKT) cells promotes pancreatic cancer in LSL-Kras(G12D/+) mice. Immunology
Gunderson CC, Ding K, Dvorak J, et al. (2016) The pro-inflammatory effect of obesity on high grade serous ovarian cancer. Gynecologic Oncology
Walgama C, Al Mubarak ZH, Zhang B, et al. (2016) Label-free Real-time Microarray Imaging of Cancer Protein-Protein Interactions and Their Inhibition by Small Molecules. Analytical Chemistry
Chandra V, Kim JJ, Benbrook DM, et al. (2016) Therapeutic options for management of endometrial hyperplasia Journal of Gynecologic Oncology. 27
Okon IS, Ding Y, Coughlan KA, et al. (2015) Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancers. Oncotarget
Ozpolat B, Benbrook DM. (2015) Targeting autophagy in cancer management - strategies and developments. Cancer Management and Research. 7: 291-9
Gnanasekaran KK, Benbrook DM, Nammalwar B, et al. (2015) Synthesis and evaluation of second generation Flex-Het scaffolds against the human ovarian cancer A2780 cell line. European Journal of Medicinal Chemistry. 96: 209-17
See more...